United Therapeutics Stock Performance

United Therapeutics Relative Risk vs. Return Landscape

If you would invest  47,720  in United Therapeutics on November 22, 2025 and sell it today you would earn a total of  332.00  from holding United Therapeutics or generate 0.7% return on investment over 90 days. United Therapeutics is currently generating 0.0195% in daily expected returns and assumes 1.2534% risk (volatility on return distribution) over the 90 days horizon. In different words, 11% of stocks are less volatile than United, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days United Therapeutics is expected to generate 5.49 times less return on investment than the market. In addition to that, the company is 1.67 times more volatile than its market benchmark. It trades about 0.02 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.14 per unit of volatility.

United Therapeutics Target Price Odds to finish over Current Price

Given the investment horizon of 90 days United Therapeutics has a beta of 0.31. This usually implies as returns on the market go up, United Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding United Therapeutics will be expected to be much smaller as well. Additionally United Therapeutics has an alpha of 0.0391, implying that it can generate a 0.0391 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for United Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as United Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 479.51 480.75 481.99 Details

Intrinsic Valuation Low Real High 432.47 512.21 513.45 Details

Naive Forecast Low Next High 469.51 470.76 472.00 Details

14 Analysts Consensus Low Target High 490.11 538.58 597.83 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as United Therapeutics. Your research has to be compared to or analyzed against United Therapeutics' peers to derive any actionable benefits. When done correctly, United Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in United Therapeutics.

United Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. United Therapeutics is not an exception. The market had few large corrections towards the United Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold United Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of United Therapeutics within the framework of very fundamental risk indicators.

United Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of United Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for United Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

United Therapeutics Price Density Drivers

United Therapeutics Fundamentals Growth

When running United Therapeutics' price analysis, check to measure United Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy United Therapeutics is operating at the current time. Most of United Therapeutics' value examination focuses on studying past and present price action to predict the probability of United Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move United Therapeutics' price. Additionally, you may evaluate how the addition of United Therapeutics to your portfolios can decrease your overall portfolio volatility.